{
  "DOI": "10.1038/sj.ejhg.5200880",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.ejhg.5200880",
  "alternative-id": [
    "BF5200880"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Dagan",
      "given": "Efrat",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Friedman",
      "given": "Eitan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Paperna",
      "given": "Tamar",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Carmi",
      "given": "Nirit",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gershoni-Baruch",
      "given": "Ruth",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2002,
        10,
        29
      ]
    ],
    "date-time": "2002-10-29T11:57:36Z",
    "timestamp": 1035892656000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T01:28:55Z",
    "timestamp": 1684373335000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        13
      ]
    ],
    "date-time": "2023-10-13T07:19:09Z",
    "timestamp": 1697181549369
  },
  "is-referenced-by-count": 31,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "11",
  "issued": {
    "date-parts": [
      [
        2002,
        10,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "11",
    "published-print": {
      "date-parts": [
        [
          2002,
          11
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2002,
            10,
            29
          ]
        ],
        "date-time": "2002-10-29T00:00:00Z",
        "timestamp": 1035849600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/5200880",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5200880.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5200880.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "724-728",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2002,
        10,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2002,
        10,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2002,
        11
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/nm1196-1179",
      "author": "P Tonin",
      "doi-asserted-by": "publisher",
      "first-page": "1179",
      "journal-title": "Nat Med",
      "key": "BF5200880_CR1",
      "unstructured": "Tonin P, Weber B, Offit K et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families Nat Med 1996 2: 1179–1183",
      "volume": "2",
      "year": "1996"
    },
    {
      "author": "D Abeliovich",
      "first-page": "505",
      "journal-title": "Am J Hum Genet",
      "key": "BF5200880_CR2",
      "unstructured": "Abeliovich D, Kaduri L, Lerer I et al. The founder mutation 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 1997 60: 505–514",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJM199705153362002",
      "author": "FJ Couch",
      "doi-asserted-by": "publisher",
      "first-page": "1409",
      "journal-title": "N Engl J Med",
      "key": "BF5200880_CR3",
      "unstructured": "Couch FJ, DeShano ML, Blackwood MA et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 1997 336: 1409–1415",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "publisher",
      "first-page": "1401",
      "journal-title": "N Engl J Med",
      "key": "BF5200880_CR4",
      "unstructured": "Struewing JP, Hartge P, Wacholder J et al. The risk of cancer associated with specific mutations in BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 1997 336: 1401–1408",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "publisher",
      "first-page": "700",
      "journal-title": "An J Hum Genet",
      "key": "BF5200880_CR5",
      "unstructured": "Risch HA, McLaughlin JR, Cole DE et al. Prevalence and penetrance of gernline BRCA1 and BRCA2 mutations in population series of 649 women with ovarian cancer An J Hum Genet 2001 68: 700–710",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng1095-198",
      "author": "JP Struewing",
      "doi-asserted-by": "publisher",
      "first-page": "198",
      "journal-title": "Nat Genet",
      "key": "BF5200880_CR6",
      "unstructured": "Struewing JP, Abeliovich D, Peretz T et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals Nat Genet 1995 11: 198–200",
      "volume": "11",
      "year": "1995"
    },
    {
      "DOI": "10.1038/ng1096-188",
      "author": "C Oddoux",
      "doi-asserted-by": "publisher",
      "first-page": "188",
      "journal-title": "Nat Genet",
      "key": "BF5200880_CR7",
      "unstructured": "Oddoux C, Struewing JP, Clayton CM et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% Nat Genet 1996 14: 188–190",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1038/ng1096-185",
      "author": "BB Roa",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Nat Genet",
      "key": "BF5200880_CR8",
      "unstructured": "Roa BB, Boyd AA, Volcik K, Richards CS . Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 Nat Genet 1996 14: 185–187",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/91.14.1241",
      "author": "E Warner",
      "doi-asserted-by": "publisher",
      "first-page": "1241",
      "journal-title": "J Natl Cancer Inst",
      "key": "BF5200880_CR9",
      "unstructured": "Warner E, Foulks W, Goodwin P et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 1999 91: 1241–1247",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1056/NEJM200107263450401",
      "author": "B Modan",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "journal-title": "N Engl J Med",
      "key": "BF5200880_CR10",
      "unstructured": "Modan B, Hartge P, Hirsch-Yechezkel G et al and the National Israel Ovarian Cancer Study Group. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and non carriers of a BRCA1 or BRCA2 mutation N Engl J Med 2001 345: 235–240",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.284.5418.1354",
      "author": "S Fan",
      "doi-asserted-by": "publisher",
      "first-page": "1354",
      "journal-title": "Science",
      "key": "BF5200880_CR11",
      "unstructured": "Fan S, Wang J, Yuan R et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells Science 1999 284: 1354–1356",
      "volume": "284",
      "year": "1999"
    },
    {
      "author": "RU Irvine",
      "first-page": "1937",
      "journal-title": "Cancer Res",
      "key": "BF5200880_CR12",
      "unstructured": "Irvine RU, Yu MC, Ross RK, Coetzee GA . The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibirium in men with prostate cancer Cancer Res 1995 55: 1937–1940",
      "volume": "55",
      "year": "1995"
    },
    {
      "DOI": "10.1073/pnas.94.7.3320",
      "author": "E Giovannucci",
      "doi-asserted-by": "publisher",
      "first-page": "3320",
      "journal-title": "Proc Acad Sci USA",
      "key": "BF5200880_CR13",
      "unstructured": "Giovannucci E, Stampfer MJ, Krithivas K et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proc Acad Sci USA 1997 94: 3320–3323",
      "volume": "94",
      "year": "1997"
    },
    {
      "author": "DO Hardy",
      "first-page": "4400",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "BF5200880_CR14",
      "unstructured": "Hardy DO, Scher HI, Bogenreider T et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset J Clin Endocrinol Metab 1996 81: 4400–4405",
      "volume": "81",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/91.11.961",
      "author": "AB Spurdle",
      "doi-asserted-by": "publisher",
      "first-page": "961",
      "journal-title": "J Natl Cancer Inst",
      "key": "BF5200880_CR15",
      "unstructured": "Spurdle AB, Dite GS, Chen X et al. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years J Natl Cancer Inst 1999 91: 961–966",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1093/carcin/20.11.2131",
      "author": "AM Dunning",
      "doi-asserted-by": "publisher",
      "first-page": "2131",
      "journal-title": "Carcinogenesis",
      "key": "BF5200880_CR16",
      "unstructured": "Dunning AM, McBride S, Gregory J et al. No association between androgen and vitamin D receptor gene polymorphisms and risk of breast cancer Carcinogenesis 1999 20: 2131–2135",
      "volume": "20",
      "year": "1999"
    },
    {
      "author": "Y Giguere",
      "first-page": "5869",
      "journal-title": "Cancer Res",
      "key": "BF5200880_CR17",
      "unstructured": "Giguere Y, Dewailly E, Brisson J et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population Cancer Res 2001 61: 5869–5874",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1086/302366",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1371",
      "journal-title": "Am J Hum Genet",
      "key": "BF5200880_CR18",
      "unstructured": "Rebbeck TR, Kantoff PW, Krithivas K et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat Am J Hum Genet 1999 64: 1371–1377",
      "volume": "64",
      "year": "1999"
    },
    {
      "DOI": "10.1093/clinchem/43.1.24",
      "author": "EM Rohlfs",
      "doi-asserted-by": "crossref",
      "first-page": "24",
      "journal-title": "Clin Chem",
      "key": "BF5200880_CR19",
      "unstructured": "Rohlfs EM, Learning WG, Friedman KJ, Couch FJ, Weber BL, Silverman LM . Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis Clin Chem 1997 43: 24–29",
      "volume": "43",
      "year": "1997"
    },
    {
      "author": "R Shiri-Sverdlov",
      "first-page": "50",
      "journal-title": "Community Genet",
      "key": "BF5200880_CR20",
      "unstructured": "Shiri-Sverdlov R, Gershoni-Baruch R, Ichezkel-Hirsch G et al. The Tyr978X BRCA1 mutation in non-Ashkenazi Jews: occurrence in high-risk families, general population and unselected ovarian cancer patients Community Genet 2001 4: 50–55",
      "volume": "4",
      "year": "2001"
    },
    {
      "key": "BF5200880_CR21",
      "unstructured": "Szabo CI, van Eijk R, Schreiber M, Kadouri L, Csokay B, Kote-Jarai Z . Andrgen Receptor cag repeat length and BRCA1 assocoated breast cancer risk: size does matter Presented in the International Collaborative Group on Familial Breast/Ovarian Cancer, Venice, pp 2001 (abstract # 6)"
    },
    {
      "DOI": "10.1054/bjoc.2001.1777",
      "author": "L Kadouri",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Br J Cancer",
      "key": "BF5200880_CR22",
      "unstructured": "Kadouri L, Easton DF, Edwards S et al. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers Br J Cancer 2001 85: 36–40",
      "volume": "85",
      "year": "2001"
    },
    {
      "author": "DA Levine",
      "first-page": "908",
      "journal-title": "Cancer Res",
      "key": "BF5200880_CR23",
      "unstructured": "Levine DA, Boyd J . The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series Cancer Res 2001 61: 908–911",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1093/nar/22.15.3181",
      "author": "NL Chamberlain",
      "doi-asserted-by": "publisher",
      "first-page": "3181",
      "journal-title": "Nucleic Acid Res",
      "key": "BF5200880_CR24",
      "unstructured": "Chamberlain NL, Driver ED, Meisfeld RL . The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function Nucleic Acid Res 1994 22: 3181–3186",
      "volume": "22",
      "year": "1994"
    },
    {
      "DOI": "10.1016/0960-0760(95)00005-K",
      "author": "SN Birrel",
      "doi-asserted-by": "publisher",
      "first-page": "459",
      "journal-title": "J Steroid Biochem Mol Biol",
      "key": "BF5200880_CR25",
      "unstructured": "Birrel SN, Bentel JM, Hickey TE et al. Androgen induce divergent proliferative responses in human breast cancer cell lines J Steroid Biochem Mol Biol 1995 52: 459–467",
      "volume": "52",
      "year": "1995"
    },
    {
      "DOI": "10.1023/A:1006356502820",
      "author": "H Yu",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BF5200880_CR26",
      "unstructured": "Yu H, Bharaj B, Vassilikos EJ, Giani M, Diamandis EP . Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer Breast Cancer Res Treat 2000 59: 153–161",
      "volume": "59",
      "year": "2000"
    }
  ],
  "reference-count": 26,
  "references-count": 26,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/5200880"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype"
  ],
  "type": "journal-article",
  "volume": "10"
}